NorthSea Therapeutics
PrivateLast Round
Series C
Dec 17, 2021
Total Funding Raised
$149.5M
Company Overview
NorthSea Therapeutics operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Series C round in December 2021.
NorthSea Therapeutics is a biotechnology company that develops novel therapeutic drugs for metabolic, inflammatory, and liver diseases using its proprietary Structurally Engineered Fatty Acid (SEFA) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NorthSea Therapeutics Comparables
Compare NorthSea Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagimet Biosciences | 82% | |
| Therasid Bioscience | 82% | |
| Inventiva S.A. | 80% |
For institutional investors. Book with your work email.
NorthSea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 17, 2021 | ||||
| Series B | Jan 8, 2020 | ||||
| Series A | Dec 12, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NorthSea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Series C |
| Forbion | Series B, Series C, Series A |
| Ysios Capital | Series C |
| Flerie Invest | Series C, Series A, Series B |
| Novo Holdings | Series B, Series C, Series A |
| Novoseeds | Series B, Series C, Series A |
| venBio | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 56% MoM.
- Apr 20, 2026
Monthly visitors grew 503% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 2, 2026
NorthSea Therapeutics B.V attends AASLD The Liver Meeting(R) 2026 in Colorado and presents Phase 2 topline data for orziloben in intestinal failure-associated liver disease on Nov 8th '26.
For institutional investors. Book with your work email.
NorthSea Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NorthSea Therapeutics's valuation, stock price, and market status.
Is NorthSea Therapeutics a public or private company?
NorthSea Therapeutics is a private company.
What is the current stock price of NorthSea Therapeutics?
NorthSea Therapeutics is a private company, so its shares have no public market price. Caplight tracks NorthSea Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NorthSea Therapeutics worth (valuation)?
Valuation information for NorthSea Therapeutics is not publicly available.
Can I buy NorthSea Therapeutics stock?
NorthSea Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NorthSea Therapeutics's last funding round?
NorthSea Therapeutics's most recent funding round was Series C on December 17, 2021.
Who are the main investors in NorthSea Therapeutics?
Key investors in NorthSea Therapeutics include Forbion, Ysios Capital, Flerie Invest, venBio, BioGeneration Ventures.
Will NorthSea Therapeutics IPO soon?
No public IPO plans have been announced for NorthSea Therapeutics.
How can I track NorthSea Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NorthSea Therapeutics's shares on secondary markets.